BIOMETRIC HEAD-TO-HEAD // THE RING VS THE STRAP
REVISION LOG — 4 ENTRIESMOST RECENT: 2026-09-30
- 2026-09-30CORRECTION — premise. Earlier revisions said no controlled head-to-head of Oura and WHOOP existed. That was wrong. Miller et al. (2022) put both on the same 53 adults for one laboratory night, against polysomnography and ECG. Dial et al. (2025) compared both within one study — 13 adults at home, the same chest-strap ECG reference, several devices worn together each night, 536 nights in total — but reports each device over its own nights (Oura Gen4 138, WHOOP 4.0 288) and does not say which nights the two shared, or compare them pair by pair. The comparison is rewritten on these two. Sleep staging (Miller only): tied, 61% vs 60% of epochs. Overnight heart rate and HRV: WHOOP ahead in 2022 — older devices, a WHOOP-supported laboratory, WHOOP-supplied data — by a wide margin on HRV (ICC 0.99 vs 0.63); Oura ahead in 2025 — newer devices, no declared conflict — by a small margin. Exercise: measured by no study cited, so the statement that WHOOP's agreement held 'including exercise' is withdrawn, and so is 'the ring is the tighter instrument'. Conflicts are now stated for both sides, and the current models (Oura Ring 5, WHOOP 5.0, WHOOP MG) are named as untested in our sources. The comparison chart now shows the same-night data (Miller 2022, Table 3) instead of figures from separate studies. GRADE UNCHANGED — CONSUMER-VALIDATED, E·C·I 74 · 70 · 86. The new comparisons add direct evidence, but both are small, the 2022 study runs through a WHOOP-supported laboratory with WHOOP-supplied data, and the Oura-side sleep validation was funded by Oura. Those facts offset the gain. The open review of 2026-09-30 is closed.
- 2026-09-30CORRECTION — source link. The reference labelled "WHOOP HR/HRV vs ECG — Miller et al. (2022)" pointed to the wrong paper: PMID 35084003, a physical-chemistry article on magnetic coordination clusters. It now points to the study it names: Miller, Sargent & Roach, Sensors 2022 (PMID 36016077). That study tested six wearables, including Oura Gen2 and WHOOP 3.0, against polysomnography and ECG over one laboratory night (n=53). The label is corrected to match. This entry changes no grade and no E·C·I score. The same check found that this study is itself a same-night comparison of both devices, which contradicts this dossier's statement that no head-to-head exists. That review is open; the grade stands until it closes. The same study measured only nocturnal rest, with WHOOP 3.0; this dossier's statement that agreement held 'including exercise' is under the same open review. Found by an internal drift check, not by a reader.
- 2026-08-01Deployed full O.B.M. deep-analysis: Oura (recovery/sleep instrument, tighter PSG staging + thermal flag) vs WHOOP (training-load instrument, ECG-grade continuous HR ICC≈0.99, looser sleep staging). Truth-first: no controlled head-to-head exists — graded directional, matched to the operator's bottleneck, no crowned winner.
- 2026-07-04Initial head-to-head issued; sleep-stage bias comparison chart (Oura vs WHOOP) added.
Every entry above was written when the change was made, not reconstructed afterwards. Where we were wrong, the wrong version is named.
Oura (a finger ring) and WHOOP (a strap, worn on the wrist in both comparisons) have now been compared in two small studies. On one laboratory night against polysomnography, with both worn at once, they tied on sleep stages: 61% of epochs correct for Oura, 60% for WHOOP. On overnight heart rate and HRV the studies disagree, and they do not weigh the same. The 2022 test — older devices, one night, 53 adults, a laboratory WHOOP supports, heartbeat data supplied by WHOOP — put WHOOP ahead, by a wide margin on HRV (ICC 0.99 vs 0.63). The 2025 study — newer devices, 13 adults at home, no declared conflict, several devices worn each night but each reported over its own nights — put Oura ahead by a small margin. Every device in both studies has since been superseded. Neither device is medical.
Two studies have now measured both devices against the same reference in the same cohort. Miller et al. (2022) put Oura Gen2 and WHOOP 3.0 on 53 adults for one laboratory night, worn at once, against polysomnography and ECG. Dial et al. (2025) followed 13 adults at home against the same chest-strap ECG, several devices worn together each night, 536 nights in total. It reports each device over its own nights — Oura Gen4 on 138, WHOOP 4.0 on 288 — and does not say which nights the two shared, or compare them pair by pair. Earlier revisions of this dossier said no such comparison existed. That was wrong.
The findings are modest. On sleep stages only the laboratory night can speak, and there the two were level: 61% of epochs correct for Oura, 60% for WHOOP. On overnight heart rate and HRV the studies disagree, and their results are not equal in weight. The 2022 test used older devices, one night and a laboratory WHOOP supports, with heartbeat data WHOOP supplied; WHOOP led, and on HRV by a wide margin — ICC 0.99 against 0.63 for Oura Gen2. The 2025 study used newer devices and declares no conflict; Oura led by a small margin, and the older Oura Gen3, over 470 nights, led as well. Both samples are small. Neither study tested exercise.
Oura — The RingTIER A (SLEEP / OVERNIGHT HR)
Against multi-night polysomnography, Oura Gen3 reached 91.7–91.8% sleep/wake accuracy and per-stage accuracy from 75.5% (light) to 90.6% (REM); time in light and deep sleep did not differ significantly from PSG, and REM was underestimated by 4.1–5.6 minutes. That study was funded by Oura, and its per-stage accuracy is a different measure from the epoch agreement that follows. On the same laboratory night as WHOOP 3.0, Oura Gen2 identified 61% of epochs (κ 0.43): ahead on light sleep, behind on REM, level on deep.
At home, against a chest-strap ECG, Oura Gen4's overnight resting heart rate and HRV reached CCC 0.98 and 0.99, over 138 and 139 nights. In the 2022 laboratory test the older Gen2, read from its app, trailed: ICC 0.85 for heart rate, 0.63 for HRV. The ring also reports a skin-temperature trend; nothing this dossier cites validates it.
If you want sleep and recovery tracking and would rather not wear anything on your wrist, the ring does the job. It is not the more accurate sleep instrument — on the one same-night test, it tied.
WHOOP — The StrapTIER A (OVERNIGHT HR) · TIER C (STRAIN)
Worn on the wrist, WHOOP 3.0 matched the laboratory ECG closely overnight: ICC 0.99 for heart rate and 0.99 for HRV, measured across the night's sleep (Miller et al., 2022). WHOOP staff supplied the raw heartbeat intervals for that test, blind to the ECG; Oura, invited to supply its own data, did not. In the 2025 study WHOOP 4.0 trailed Oura over 288 nights: CCC 0.91 for resting heart rate and 0.94 for HRV. None of the studies this dossier cites measured either device during exercise.
WHOOP builds its product around a training-load ('strain') score. Nothing this dossier cites validates that score. On sleep stages the strap was level with the ring on the same laboratory night (60% of epochs, κ 0.44), ahead on REM (66% vs 52%), behind on light sleep (58% vs 66%).
If you want a wrist device built around training load, WHOOP is designed for it. Its sleep-stage numbers match the ring's; its overnight heart numbers led in the older test and trailed in the newer one; its strain score is unvalidated here.
Side by side, the data neither crowns a winner nor hands out clean jobs. The one same-night test ties them on sleep stages; on heart rate and HRV the two studies disagree.
One laboratory night, the same 53 adults wearing both: Oura 61% of epochs (κ 0.43), WHOOP 60% (κ 0.44). Oura ahead on light sleep, WHOOP ahead on REM, level on deep.
Six wearables incl. Oura Gen2 & WHOOP 3.0 vs PSG and ECG, one lab night, n=53 — Miller et al., Sensors (2022) ↗2022 — same night, older devices, WHOOP-supported lab, WHOOP-supplied data: WHOOP ahead, ICC 0.99 vs 0.85 (HR) and 0.99 vs 0.63 (HRV). 2025 — same study, each device over its own nights; newer devices, no declared conflict: Oura Gen4 ahead, CCC 0.98 vs 0.91 (HR) and 0.99 vs 0.94 (HRV), over 138 and 288 nights. Both small: n=53 and n=13.
Oura Gen3, Oura Gen4 & WHOOP 4.0 (with Garmin, Polar) vs chest-strap ECG, overnight HR/HRV at home, n=13, 536 nights in total — Dial et al., Physiol Rep (2025) ↗Neither study tested exercise, daytime wear or the strain score, and both are small. A ranked 'best wearable' has no evidence behind it. For most operators, owning both is redundant.
Six wearables incl. Oura Gen2 & WHOOP 3.0 vs PSG and ECG, one lab night, n=53 — Miller et al., Sensors (2022) ↗At night both are validated, trend-grade instruments. On sleep stages the one same-night test ties them. On overnight heart rate and HRV, the 2025 study (newer devices, independent) put Oura slightly ahead and the 2022 test (older devices, WHOOP-backed) put WHOOP well ahead on HRV — and every device in both studies has since been superseded. Nothing we cite measured either during exercise. OCCABUZZ will not crown one: wear the device you will actually keep on every night, and read trends, not single nights.
The one same-night test ties these two on sleep stages, and the two studies do not agree on which is ahead on overnight heart rate and HRV: the 2025 study favours Oura by a small margin, the 2022 test favoured WHOOP by a wide margin on HRV. Every device in both has since been replaced. Neither is diagnostic, no study we cite measured either during exercise, and neither current model — Oura Ring 5, WHOOP 5.0 or WHOOP MG — has been independently tested in anything we cite. OCCABUZZ deploys the device the operator will wear every night and treats any 'objectively best wearable' claim as marketing.
- ›Sleep and recovery tracking without a wrist device → Oura. It tied the strap on sleep stages in the same-night test.
- ›A wrist device built around a training-load score → WHOOP. The score itself is unvalidated in anything we cite.
- ›Either way: act on multi-day trends, not single nights. Both drift by fit, skin, and placement.
Worn together for a night, the two tie on sleep stages. On heart rate and HRV, the 2025 study has Oura ahead by a small margin; the 2022 test, older and WHOOP-backed, had WHOOP ahead by a wide margin on HRV (0.99 vs 0.63). The devices in both studies are already superseded. Buying both is redundant for most — pick the one you will wear every night and act on its trends.
Certainty ends at the size, design, funding and age of the evidence. Only one comparison is known to have put both devices on the same night: 53 adults for one laboratory night. The other followed 13 adults at home against the same chest-strap ECG, several devices worn together each night, 536 nights in total; it reports each device over its own nights — Oura Gen4 on 138, WHOOP 4.0 on 288 — and does not say which nights the two shared, or compare them pair by pair. Both measured sleep and rest only; neither tested exercise. Each side carries a conflict. The laboratory behind the 2022 study receives research support from WHOOP, though the paper states WHOOP was not involved in its design, conduct or reporting. The Oura-only sleep validation we cite was funded by Oura Health. The 2025 study declares none. One asymmetry in the 2022 method favours WHOOP: invited to supply their own data, WHOOP did and Oura did not, so WHOOP's heartbeat data arrived raw and its staging came from WHOOP's own system, supplied by staff blind to the lab reference, while Oura's were read from its consumer app. The per-stage accuracy from the Oura-only study and the epoch agreement from the same-night test are different measures; do not compare them directly. The devices tested are already a generation behind: the newest in anything we cite are Oura Gen4 and WHOOP 4.0, and the current models — Oura Ring 5, announced 28 May 2026, and WHOOP 5.0 and WHOOP MG — have no independent validation in this dossier's sources. Consumer-grade, not diagnostic.
Peer-reviewed trials — sample size, effect size, stage.
Applies to healthy apex, not only to clinical deficit.
Survives a demanding calendar. Zero executive friction.
Cleared all three layers. Protocol-grade.
The score is a geometric mean — a single failed layer collapses it. Excellence in two cannot rescue a gap in the third. That is why hype scores low and proven, feasible, broadly-applicable work scores high. The restraint is the product.